We were excited this week to announce a new collaboration between TripleBlind and the Mayo Clinic. Mayo plans to use TripleBlind’s solution to validate interoperability of encrypted algorithms on encrypted data and training of new algorithms on encrypted data. Our solution will enable Mayo and other health care systems to generate insights from highly regulated data without actually accessing the data – ensuring compliance with HIPAA and other standards.
Today, health care systems have to either transfer data or algorithms outside their institution for experts to train or conduct research. This process can take many months and typically involves complicated legal contracts and a significant amount of time from technicians. Our solution eliminates this step, further protecting intellectual property.
Suraj Kapa, M.D., a practicing cardiologist and director of AI for knowledge management and delivery at Mayo Clinic, noted:
“Training novel algorithms on encrypted data sets and facilitating trust between independent parties is critical to the future of AI in medicine. By using advanced mathematical encryption technologies, we will greatly enhance scientific collaboration between groups and allow for more rapid development and scalable implementation of AI-driven tools to advance healthcare.”
TripleBlind’s advanced mathematics toolset will allow Mayo to improve the current process by enabling Mayo technicians to perform diagnostic services using data wherever it resides. The collaboration focuses on three milestones. The first milestone includes validating that an algorithm already created and “trained” at Mayo can be delivered to remote hospitals and used locally to achieve accurate diagnoses. This milestone will also demonstrate that TripleBlind’s toolset provides accurate information and effectively enforces appropriate data privacy regulations such as GDPR, HIPAA, data residency regulations and other standards.
The second milestone will demonstrate that TripleBlind’s toolset can be applied to train an algorithm that resides at Mayo to access data remotely and provide diagnostic services. The third milestone will consist of demonstrating that TripleBlind’s solution can support any type of medical data and potentially genetic data in particular. Genetic data is especially difficult to aggregate since almost by definition it is impossible to deidentify using conventional approaches.
We are eager to work together with the Mayo Clinic to assist them in providing more and better services to health care systems around the country.
This news follows TripleBlind’s recent announcement it has received funding and marketing support from Accenture Ventures, the investment arm of global professional services company Accenture (NYSE: ACN). TripleBlind is applying this funding to further refine our solution.
We wish our colleagues, partners, investors and other friends of the company the best for the holiday season. We will have another announcement highlighting our growth in early January, please check back then.